Prevalence and antimicrobial susceptibility of virulent and avirulent multidrug-resistant Escherichia coli isolated from diarrheic neonatal calves

Robert Barigye Department of Veterinary and Microbiological Sciences, College of Agriculture, Food Systems, and Natural Resources, North Dakota State University, Fargo, ND 58108.

Search for other papers by Robert Barigye in
Current site
Google Scholar
PubMed
Close
 BVM, PhD
,
Ablesh Gautam Department of Veterinary and Microbiological Sciences, College of Agriculture, Food Systems, and Natural Resources, North Dakota State University, Fargo, ND 58108.

Search for other papers by Ablesh Gautam in
Current site
Google Scholar
PubMed
Close
 BVSc & AH, MS
,
Lisa M. Piche Department of Veterinary Diagnostic Services, College of Agriculture, Food Systems, and Natural Resources, North Dakota State University, Fargo, ND 58108.

Search for other papers by Lisa M. Piche in
Current site
Google Scholar
PubMed
Close
 MS
,
Lynn P. Schaan Department of Veterinary Diagnostic Services, College of Agriculture, Food Systems, and Natural Resources, North Dakota State University, Fargo, ND 58108.

Search for other papers by Lynn P. Schaan in
Current site
Google Scholar
PubMed
Close
 BS
,
Darlene F. Krogh Department of Veterinary Diagnostic Services, College of Agriculture, Food Systems, and Natural Resources, North Dakota State University, Fargo, ND 58108.

Search for other papers by Darlene F. Krogh in
Current site
Google Scholar
PubMed
Close
 BS
, and
Susan Olet Department of Statistics, College of Science and Mathematics, North Dakota State University, Fargo, ND 58108.

Search for other papers by Susan Olet in
Current site
Google Scholar
PubMed
Close
 M Biostat

Abstract

Objective—To determine the prevalence of selected virulence genes and the antimicrobial susceptibility of multidrug-resistant (MDR) Escherichia coli isolated from diarrheic neonatal calves.

Sample—97 E coli isolates from diarrheic neonatal calves.

ProceduresE coli isolates were tested via PCR assay for 6 virulence genes and susceptibility to 17 drugs belonging to 9 classes. A 2-sample test of proportions was used to make comparisons between proportions of virulent and avirulent MDR isolates.

Results—23 of 97 (23.7%) isolates were virulent, and 74 (76.3%) were avirulent. Of the 23 virulent isolates, 15 (65.2%) were positive for K99, 14 (60.9%) for F41, 12 (52.2%) for STa, 9 (39.1%) for Stx1, 6 (26.1%) for intimin, and 0 (0%) for Stx2. Twenty of 23 (87.0%) virulent isolates expressed ≥ 2 virulence genes, and 3 of 23 (13.0%) were positive for 1 virulence factor. Eight of 23 (34.8%) virulent isolates expressed STa, K99, and F41, whereas 1 of 23 (4.4%) was positive for STa, F41, intimin, and Stx1. The second most frequent gene pattern was Stx1 and intimin. Twenty of 23 (87.0%) virulent isolates were MDR; the highest prevalence of resistance was recorded for the macrolide-lincosides, followed by the tetracyclines and penicillins. Also, 17 of 23 (74.0%) virulent isolates were resistant to sulfadimethoxine, and 10 of 23 (43.5%) were resistant to trimethoprim-sulfamethoxazole. Additionally, 60 of 74 (81.0%) avirulent isolates were MDR.

Conclusions and Clinical Relevance—The prevalence of multidrug resistance was comparable for virulent and avirulent E coli isolated from diarrheic neonatal calves. Cephalosporins and aminoglycosides had reasonable susceptibility.

Abstract

Objective—To determine the prevalence of selected virulence genes and the antimicrobial susceptibility of multidrug-resistant (MDR) Escherichia coli isolated from diarrheic neonatal calves.

Sample—97 E coli isolates from diarrheic neonatal calves.

ProceduresE coli isolates were tested via PCR assay for 6 virulence genes and susceptibility to 17 drugs belonging to 9 classes. A 2-sample test of proportions was used to make comparisons between proportions of virulent and avirulent MDR isolates.

Results—23 of 97 (23.7%) isolates were virulent, and 74 (76.3%) were avirulent. Of the 23 virulent isolates, 15 (65.2%) were positive for K99, 14 (60.9%) for F41, 12 (52.2%) for STa, 9 (39.1%) for Stx1, 6 (26.1%) for intimin, and 0 (0%) for Stx2. Twenty of 23 (87.0%) virulent isolates expressed ≥ 2 virulence genes, and 3 of 23 (13.0%) were positive for 1 virulence factor. Eight of 23 (34.8%) virulent isolates expressed STa, K99, and F41, whereas 1 of 23 (4.4%) was positive for STa, F41, intimin, and Stx1. The second most frequent gene pattern was Stx1 and intimin. Twenty of 23 (87.0%) virulent isolates were MDR; the highest prevalence of resistance was recorded for the macrolide-lincosides, followed by the tetracyclines and penicillins. Also, 17 of 23 (74.0%) virulent isolates were resistant to sulfadimethoxine, and 10 of 23 (43.5%) were resistant to trimethoprim-sulfamethoxazole. Additionally, 60 of 74 (81.0%) avirulent isolates were MDR.

Conclusions and Clinical Relevance—The prevalence of multidrug resistance was comparable for virulent and avirulent E coli isolated from diarrheic neonatal calves. Cephalosporins and aminoglycosides had reasonable susceptibility.

Contributor Notes

Dr. Barigye's present address is Berrimah Veterinary Laboratories, Department of Resources, GPO Box 3000, Darwin, NT 0801, Australia.

Dr. Gautam's present address is Maxwell H. Gluck Equine Research Center, Department of Veterinary Science, College of Agriculture, University of Kentucky, Lexington, KY 40546.

Supported by the USDA APHIS (Biosurveillance grant No. FARG014465).

Address correspondence to Dr. Barigye (Robert.Barigye@nt.gov.au).
  • 1. Taxt A, Aasland R, Sommerfelt H, et alHeat-stable enterotoxin of enterotoxigenic Escherichia coli as a vaccine target. Infect Immun 2010;78:18241831.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 2. Orden JA, Yuste M, Cid D, et alTyping of the eae and espB genes of attaching and effacing Escherichia coli isolates from ruminants. Vet Microbiol 2003;96:203215.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3. Franck SM, Bosworth BT, Moon HW. Multiplex PCR for enterotoxigenic, attaching and effacing, and Shiga toxin-producing Escherichia coli strains from calves. J Clin Microbiol 1998;36:17951797.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4. Beutin L, Geier D, Steinruck H, et alPrevalence and some properties of verotoxin (Shiga-like toxin)-producing Escherichia coli in seven different species of healthy domestic animals. J Clin Microbiol 1993;31:24832488.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5. Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991;13:6098.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 6. Beutin L, Krause G, Zimmermann S, et alCharacterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J Clin Microbiol 2004;42:10991108.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 7. Blanco M, Padola NL, Kruger A, et alVirulence genes and intimin types of Shiga-toxin-producing Escherichia coli isolated from cattle and beef products in Argentina. Int Microbiol 2004;7:269276.

    • Search Google Scholar
    • Export Citation
  • 8. Meng J, Zhao S, Doyle MP. Virulence genes of Shiga toxin-producing Escherichia coli isolated from food, animals and humans. Int J Food Microbiol 1998;45:229235.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9. Johnson JR, Owens KL, Clabots CR, et alPhylogenetic relationships among clonal groups of extraintestinal pathogenic Escherichia coli as assessed by multi-locus sequence analysis. Microbes Infect 2006;8:17021713.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10. Voss E, Paton AW, Manning PA, et alMolecular analysis of Shiga toxigenic Escherichia coli O111:H- proteins which react with sera from patients with hemolytic-uremic syndrome. Infect Immun 1998;66:14671472.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11. Mainil JG, Daube G. Verotoxigenic Escherichia coli from animals, humans and foods: who's who? J Appl Microbiol 2005;98:13321344.

  • 12. Nataro JP, Kaper JB. Diarrheagenic. Escherichia coli Clin Microbiol Rev 1998;11:142201.

  • 13. Badouei MA, Salehi TZ, Khorasgani MR, et alVirulence gene profiles and intimin subtypes of Shiga toxin-producing Escherichia coli isolated from healthy and diarrhoeic calves. Vet Rec 2010;167:858861.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 14. Bandyopadhyay S, Mahanti A, Samanta I, et alVirulence repertoire of Shiga toxin-producing Escherichia coli (STEC) and enterotoxigenic Escherichia coli (ETEC) from diarrhoeic lambs of Arunachal Pradesh, India. Trop Anim Health Prod 2011;43:705710.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 15. Acres SD. Enterotoxigenic Escherichia coli infections in newborn calves: a review. J Dairy Sci 1985;68:229256.

  • 16. Mitache M, Lazar V, Bleotu C. Phenotypic and genetic virulence and antibiotic resistance markers in Escherichia coli strains isolated from hospital surfaces. Roum Arch Microbiol Immunol 2009;68:158165.

    • Search Google Scholar
    • Export Citation
  • 17. Sharma S, Bhat GK, Shenoy S. Virulence factors and drug resistance in Escherichia coli isolated from extraintestinal infections. Indian J Med Microbiol 2007;25:369373.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18. Bonnet C, Diarrassouba F, Brousseau R, et alPathotype and antibiotic resistance gene distributions of Escherichia coli isolates from broiler chickens raised on antimicrobial-supplemented diets. Appl Environ Microbiol 2009;75:69556962.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 19. Johnson TJ, Jordan D, Kariyawasam S, et alSequence analysis and characterization of a transferable hybrid plasmid encoding multidrug resistance and enabling zoonotic potential for extraintestinal Escherichia coli Infect Immun 2010;78:19311942.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 20. Gu J, Liu Y, Yu S, et alEnterohemorrhagic Escherichia coli trivalent recombinant vaccine containing EspA, intimin and Stx2 induces strong humoral immune response and confers protection in mice. Microbes Infect 2009;11:835841.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 21. Gao X, Cai K, Li T, et alNovel fusion protein protects against adherence and toxicity of enterohemorrhagic Escherichia coli O157:H7 in mice. Vaccine 2011;29:66566663.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22. McNeilly TN, Mitchell MC, Rosser T, et alImmunization of cattle with a combination of purified intimin-531, EspA and Tir significantly reduces shedding of Escherichia coli O157:H7 following oral challenge. Vaccine 2010;28:14221428.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 23. Goldstein C, Lee MD, Sanchez S, et alIncidence of class 1 and 2 integrases in clinical and commensal bacteria from livestock, companion animals, and exotics. Antimicrob Agents Chemother 2001;45:723726.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 24. van Essen-Zandbergen A, Smith H, Veldman K, et alOccurrence and characteristics of class 1, 2 and 3 integrons in Escherichia coli, Salmonella and Campylobacter spp. in the Netherlands. J Antimicrob Chemother 2007;59:746750.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25. Neyfakh AA, Bidnenko VE, Chen LB. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system. Proc Natl Acad Sci U S A 1991;88:47814785.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26. Rouveix B. Clinical implications of multiple drug resistance efflux pumps of pathogenic bacteria. J Antimicrob Chemother 2007;59:12081209.

  • 27. Tikhonova EB, Zgurskaya HI. AcrA, AcrB, and TolC of Escherichia coli form a stable intermembrane multidrug efflux complex. J Biol Chem 2004;279:3211632124.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 28. Yu EW, McDermott G, Zgurskaya HI, et alStructural basis of multiple drug-binding capacity of the AcrB multidrug efflux pump. Science 2003;300:976980.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 29. Burns JL, Smith AL. A major outer-membrane protein functions as a porin in Haemophilus influenzae J Gen Microbiol 1987;133:12731277.

    • Search Google Scholar
    • Export Citation
  • 30. Toro CS, Lobos SR, Calderon I, et alClinical isolate of a porinless Salmonella typhi resistant to high levels of chloramphenicol. Antimicrob Agents Chemother 1990;34:17151719.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31. Vinson HM, Gautam A, Olet S, et alMolecular analysis of porin gene transcription in heterogenotypic multidrug-resistant Escherichia coli isolates from scouring calves. J Antimicrob Chemother 2010;65:19261935.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 32. Frère JM. Beta-lactamases and bacterial resistance to antibiotics. Mol Microbiol 1995;16:385395.

  • 33. Thomson C, Amyes S. Novel beta-lactamases in amoxycillin-resistant Escherichia coli J Antimicrob Chemother 1993;32:777778.

  • 34. Stine OC, Johnson JA, Keefer-Norris A, et alWidespread distribution of tetracycline resistance genes in a confined animal feeding facility. Int J Antimicrob Agents 2007;29:348352.

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 35. Schnappinger D, Hillen W. Tetracyclines: antibiotic action, uptake, and resistance mechanisms. Arch Microbiol 1996;165:359369.

  • 36. Li H, Lin XM, Wang SY, et alIdentification and antibody-therapeutic targeting of chloramphenicol-resistant outer membrane proteins in Escherichia coli J Proteome Res 2007;6:36283636.

    • Crossref
    • Search Google Scholar
    • Export Citation

Advertisement